What is SA Scientific?
Established in 1984, SA Scientific operates at the intersection of biotechnology and clinical diagnostics. The company specializes in the design, development, and manufacturing of high-precision diagnostic tests and pathogen detection devices. By leveraging advanced colloidal gold lateral flow and rapid molecular test technologies, the firm provides essential tools for fertility monitoring and the identification of infectious diseases, including respiratory illnesses and food-borne pathogens. Their commitment to rigorous quality standards has made them a trusted partner for clinical laboratories worldwide, effectively bridging the gap between complex laboratory science and the urgent need for rapid, point-of-care results.
How much funding has SA Scientific raised?
SA Scientific has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in SA Scientific
PPP
Public-Private Partnership
What's next for SA Scientific?
With this late-stage funding secured, SA Scientific is well-positioned to scale its production infrastructure and accelerate the deployment of its next-generation molecular diagnostic platforms. The strategic focus will likely shift toward expanding its global distribution network and enhancing its R&D pipeline to address emerging pathogen threats. By optimizing its manufacturing processes, the company aims to meet the escalating demand for reliable, rapid detection tools in an increasingly complex global health landscape. This capital deployment serves as a critical catalyst for maintaining competitive advantage in the high-stakes diagnostic manufacturing market.
See full SA Scientific company page
